6-Month Buy/Sell Trend
Buys
Sells
▶
2026-03-30
▲ 1 buy
· $28K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | ▲ Buy | 10,000 | $3 | $28K | Mar 31 |
▶
2025-12-16
▲ 2 buys
· $57K
⚡ 2 insiders
▶
2025-12-15
▲ 6 buys
· $150K
⚡ 3 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Elam Nevan C | CEO | ▲ Buy | 32,000 | $2 | $51K | Dec 15 | |
| Evans Daron | CFO | ▲ Buy | 40,000 | $2 | $71K | Dec 15 | |
| Evans Daron | CFO | ▲ Buy | 2,500 | $2 | $4K | Dec 15 | |
| Evans Daron | CFO | ▲ Buy | 2,500 | $2 | $4K | Dec 15 | |
| Karnawat Sunil Ratilal | Chief Commercial Officer | ▲ Buy | 12,000 | $2 | $19K | Dec 15 | |
| Karnawat Sunil Ratilal | Chief Commercial Officer | ▲ Buy | 100 | $2 | $160 | Dec 15 |
▶
2025-11-19
20 other
⚡ 10 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Elam Nevan C | CEO | A | 317,000 | $0 | $0 | Nov 21 | |
| Elam Nevan C | CEO | A | 186,000 | $0 | $0 | Nov 21 | |
| Evans Daron | CFO | A | 107,000 | $0 | $0 | Nov 21 | |
| Evans Daron | CFO | A | 63,000 | $0 | $0 | Nov 21 | |
| FAUCHET PHILIPPE | — | A | 21,000 | $0 | $0 | Nov 21 | |
| FAUCHET PHILIPPE | — | A | 12,000 | $0 | $0 | Nov 21 | |
| Harris Erik | — | A | 21,000 | $0 | $0 | Nov 21 | |
| Harris Erik | — | A | 12,000 | $0 | $0 | Nov 21 | |
| Hogenhuis Wladimir | — | A | 21,000 | $0 | $0 | Nov 21 | |
| Hogenhuis Wladimir | — | A | 12,000 | $0 | $0 | Nov 21 | |
| KREHER NERISSA | — | A | 21,000 | $0 | $0 | Nov 21 | |
| KREHER NERISSA | — | A | 12,000 | $0 | $0 | Nov 21 | |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A | 32,000 | $0 | $0 | Nov 21 | |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A | 19,000 | $0 | $0 | Nov 21 | |
| Kim Young-Jin | — | A | 21,000 | $0 | $0 | Nov 21 | |
| Kim Young-Jin | — | A | 12,000 | $0 | $0 | Nov 21 | |
| Labrucherie Gil M | — | A | 21,000 | $0 | $0 | Nov 21 | |
| Labrucherie Gil M | — | A | 12,000 | $0 | $0 | Nov 21 | |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A | 123,000 | $0 | $0 | Nov 21 | |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | 72,000 | $0 | $0 | Nov 21 |
▶
2025-08-18
2 other
▶
2025-06-25
▲ 1 buy
· $11K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| ROBERTS BRIAN KENNETH | Chief Medical Officer | ▲ Buy | 2,500 | $4 | $11K | Jun 26 |
▶
2025-06-24
▲ 1 buy
· $20K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | ▲ Buy | 5,000 | $4 | $20K | Jun 24 |
▶
2025-06-13
▲ 2 buys
· $4.0M
⚡ 2 insiders
▶
2025-06-10
16 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | — | A | 9,000 | $0 | $0 | Jun 13 | |
| Hogenhuis Wladimir | — | A | 5,000 | $0 | $0 | Jun 13 | |
| KREHER NERISSA | — | A | 9,000 | $0 | $0 | Jun 13 | |
| KREHER NERISSA | — | A | 5,000 | $0 | $0 | Jun 13 | |
| Labrucherie Gil M | — | A | 9,000 | $0 | $0 | Jun 13 | |
| Labrucherie Gil M | — | A | 5,000 | $0 | $0 | Jun 13 | |
| Elam Nevan C | CEO | A | 68,000 | $0 | $0 | Jun 12 | |
| Elam Nevan C | CEO | A | 40,000 | $0 | $0 | Jun 12 | |
| Evans Daron | CFO | A | 26,000 | $0 | $0 | Jun 12 | |
| Evans Daron | CFO | A | 15,000 | $0 | $0 | Jun 12 | |
| FAUCHET PHILIPPE | — | A | 9,000 | $0 | $0 | Jun 12 | |
| FAUCHET PHILIPPE | — | A | 5,000 | $0 | $0 | Jun 12 | |
| Kim Young-Jin | — | A | 9,000 | $0 | $0 | Jun 12 | |
| Kim Young-Jin | — | A | 5,000 | $0 | $0 | Jun 12 | |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A | 26,000 | $0 | $0 | Jun 12 | |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A | 15,000 | $0 | $0 | Jun 12 |